Harriet manages The Pharmaceutical Journal's news desk. She has worked in hospital, community and industrial pharmacy and has worked as a journalist for over 14 years. She works on Mondays, Tuesdays and Wednesdays.
- 020 7572 2415
Lawyers representing health secretary Jeremy Hunt have defended his decision to slice more than £320m off the community pharmacy budget in England.
FDA approves deflazacort for Duchenne muscular dystrophy but manufacturer delays launch over price concerns
The US Food and Drug Administration has approved the first corticosteroid to be made available in the United States for the treatment of patients with Duchenne muscular dystrophy.
Twelve services provided by community pharmacy in England delivered £3bn in net value during 2015, concludes a report commissioned by the Pharmaceutical Services Negotiating Committee.
Clinical developments in 2006Subscription
Recent blog posts
A round up of the most popular news stories of 2016.
Harriet Adcock provides a rundown of the top ten news stories of 2014.